Literature DB >> 25231630

Thrombin conducts epithelial‑mesenchymal transition via protease‑activated receptor‑1 in human gastric cancer.

Tadayoshi Otsuki1, Daisuke Fujimoto1, Yasuo Hirono1, Takanori Goi1, Akio Yamaguchi1.   

Abstract

Epithelial-mesenchymal transition (EMT) is thought to be a key step for cancer metastasis. Using an immunohistochemical approach with gastric carcinoma tissue, we found the expression of protease-activated receptor-1 (PAR1), along with a metalloproteinase known to activate PAR1, were associated with poorer prognosis, compared with expression-negative tumors, and activated PAR1 promotes gastric cancer cell invasion and proliferation in vivo. In this study we observed EMT induction by the PAR1 agonist α-thrombin, in human gastric cell lines stably expressing PAR1. We investigated α-thrombin-induced changes in the cell forms of pcDNA3.1-MKN45 (MKN45/Mock), pcDNA3.1‑PAR1 transfected MKN45 (MKN45/PAR1), and MKN74. Expression levels of epithelial and mesenchymal markers as well as the distribution of transcriptional factors of E-cadherin in the cytoplasm and nucleus were also noted in these cell lines. We observed α-thrombin-induced morphological changes in MKN45/PAR1 and MKN74 cells. Western blotting and immunohistochemistry of these cells indicated a fall in the expression level of E-cadherin and an increase in fibronectin expression after 48 h. PAR1 activation also induced significant increases in nuclear levels of the Snail which is a repressor of E-cadherin gene expression. We found EMT in gastric cancer cell lines that underwent α-thrombin-induced PAR1 activation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25231630     DOI: 10.3892/ijo.2014.2651

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  ALEX1, a novel tumor suppressor gene, inhibits gastric cancer metastasis via the PAR-1/Rho GTPase signaling pathway.

Authors:  Li Pang; Jian-Fang Li; Liping Su; Mingde Zang; Zhiyuan Fan; Beiqin Yu; Xiongyan Wu; Chen Li; Min Yan; Zheng-Gang Zhu; Bingya Liu
Journal:  J Gastroenterol       Date:  2017-03-17       Impact factor: 7.527

2.  SATB2 suppresses non-small cell lung cancer invasiveness by G9a.

Authors:  Yi-Nan Ma; Hai-Yan Zhang; Liang-Ru Fei; Mei-Yu Zhang; Cong-Cong Wang; Yuan Luo; Yu-Chen Han
Journal:  Clin Exp Med       Date:  2017-06-30       Impact factor: 3.984

3.  MicroRNA Signature of Epithelial-Mesenchymal Transition in Group B Streptococcal Infection of the Placental Chorioamniotic Membranes.

Authors:  Samantha Weed; Blair Armistead; Michelle Coleman; H Denny Liggit; Brian Johnson; Jesse Tsai; Richard P Beyer; Theodor K Bammler; Nicole M Kretzer; Ed Parker; Jeroen P Vanderhoeven; Craig J Bierle; Lakshmi Rajagopal; Kristina M Adams Waldorf
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

4.  Effect of Thrombin on the Metabolism and Function of Murine Macrophages.

Authors:  Ürün Ukan; Fredy Delgado Lagos; Sebastian Kempf; Stefan Günther; Mauro Siragusa; Beate Fisslthaler; Ingrid Fleming
Journal:  Cells       Date:  2022-05-23       Impact factor: 7.666

5.  PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.

Authors:  Daisuke Fujimoto; Yuki Ueda; Yasuo Hirono; Takanori Goi; Akio Yamaguchi
Journal:  Oncotarget       Date:  2015-10-27

Review 6.  Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer.

Authors:  Xuan Liu; Jiahui Yu; Shangjin Song; Xiaoqiang Yue; Qi Li
Journal:  Oncotarget       Date:  2017-09-18

7.  KLK8 promotes the proliferation and metastasis of colorectal cancer via the activation of EMT associated with PAR1.

Authors:  Qing Hua; Zhirong Sun; Yi Liu; Xuefang Shen; Weiwei Zhao; Xiaoyan Zhu; Pingbo Xu
Journal:  Cell Death Dis       Date:  2021-09-22       Impact factor: 8.469

Review 8.  Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.

Authors:  Marek Z Wojtukiewicz; Dominika Hempel; Ewa Sierko; Stephanie C Tucker; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

9.  Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer.

Authors:  Qianqian Ren; Peng Zhu; Hui Zhang; Tianhe Ye; Dehan Liu; Zhao Gong; Xiangwen Xia
Journal:  Cancer Cell Int       Date:  2020-03-24       Impact factor: 5.722

10.  TGFβ upregulates PAR-1 expression and signalling responses in A549 lung adenocarcinoma cells.

Authors:  Natalia Smoktunowicz; Manuela Platé; Alejandro Ortiz Stern; Vanessa D'Antongiovanni; Eifion Robinson; Vijay Chudasama; Stephen Caddick; Chris J Scotton; Gabor Jarai; Rachel C Chambers
Journal:  Oncotarget       Date:  2016-10-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.